BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 19907330)

  • 1. Osteogenesis imperfecta: questions and answers.
    Shapiro JR; Sponsellor PD
    Curr Opin Pediatr; 2009 Dec; 21(6):709-16. PubMed ID: 19907330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with bisphosphonates in osteogenesis imperfecta.
    Glorieux FH
    Pediatrics; 2007 Mar; 119 Suppl 2():S163-5. PubMed ID: 17332237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenesis imperfecta, current and future medical treatment.
    Rauch F; Glorieux FH
    Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):31-7. PubMed ID: 16278881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oesteogenesis imperfecta--genetics, diagnosis and medical treatment].
    Brixen KT; Illum NO; Hansen B; Lund AM; Mosekilde L
    Ugeskr Laeger; 2007 Jan; 169(1):30-4. PubMed ID: 17217883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of osteogenesis imperfecta with bisphosphonates].
    Tau C
    Medicina (B Aires); 2007; 67(4):389-95. PubMed ID: 17891938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis imperfecta.
    Huber MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):314-20. PubMed ID: 17223585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the evaluation and treatment of osteogenesis imperfecta.
    Harrington J; Sochett E; Howard A
    Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteogenesis imperfecta: diagnosis and treatment.
    Palomo T; Vilaça T; Lazaretti-Castro M
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):381-388. PubMed ID: 28863000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of bisphosphonates in children with osteogenesis imperfecta.
    Glorieux FH
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1491-5. PubMed ID: 11837505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series.
    Schwartz S; Joseph C; Iera D; Vu DD
    J Can Dent Assoc; 2008; 74(6):537-42. PubMed ID: 18644240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteogenesis imperfecta at the beginning of bone and joint decade.
    Primorac D; Rowe DW; Mottes M; Barisić I; Anticević D; Mirandola S; Gomez Lira M; Kalajzić I; Kusec V; Glorieux FH
    Croat Med J; 2001 Aug; 42(4):393-415. PubMed ID: 11471191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterising and treating osteogenesis imperfecta.
    Bishop N
    Early Hum Dev; 2010 Nov; 86(11):743-6. PubMed ID: 20846798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment.
    Sato A; Ouellet J; Muneta T; Glorieux FH; Rauch F
    Bone; 2016 May; 86():53-7. PubMed ID: 26927310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate treatment in children with osteogenesis imperfecta.
    Akcay T; Turan S; Guran T; Bereket A
    Indian Pediatr; 2008 Feb; 45(2):105-9. PubMed ID: 18310788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?
    Rauch F; Glorieux FH
    Ann Med; 2005; 37(4):295-302. PubMed ID: 16019729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteogenesis imperfecta].
    Forin V
    Presse Med; 2007 Dec; 36(12 Pt 2):1787-93. PubMed ID: 17560761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of plasma taurine level in children affected by osteogenesis imperfecta during bisphosphonate therapy.
    D'Eufemia P; Finocchiaro R; Zambrano A; Tetti M; Ferrucci V; Celli M
    Biomed Pharmacother; 2007 May; 61(4):235-40. PubMed ID: 17275249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates.
    Malmgren B; Aström E; Söderhäll S
    J Oral Pathol Med; 2008 Apr; 37(4):196-200. PubMed ID: 18321345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate treatment of pediatric bone disease.
    Speiser PW; Clarson CL; Eugster EA; Kemp SF; Radovick S; Rogol AD; Wilson TA;
    Pediatr Endocrinol Rev; 2005 Dec; 3(2):87-96. PubMed ID: 16361982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose intravenous pamidronate treatment in osteogenesis imperfecta.
    Gökşen D; Coker M; Darcan S; Köse T; Kara S
    Turk J Pediatr; 2006; 48(2):124-9. PubMed ID: 16848111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.